The ICMR’s national task force for Covid-19 has decided against including antiviral drug molnupiravir in the clinical management protocol for Covid as of now, official sources said on Tuesday.
Molnupiravir not of much benefit, won’t keep it in protocol, says ICMR task force
byartistogram
•
0